Dipharma Receives the 2nd GMP Certification from Brazilian ANVISA
26 oct. 2023 03h59 HE
|
Dipharma Francis S.r.l
MILAN, Italy, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Dipharma Francis S.r.l. (Dipharma), a leading Contract Development and Manufacturing Organization (CDMO) and a global manufacturer of Active...
Dipharma expands its Italian R&D Center to increase its analytical services
04 avr. 2023 09h15 HE
|
Dipharma Francis S.r.l
The Company strengthens its analytical R&D capabilities,to better support its customers operating in the CDMO and Generics market. MILAN, Italy, April 04, 2023 (GLOBE NEWSWIRE) -- Dipharma...
Dipharma completes second phase of CGMP expansion at its Kalamazoo site
10 févr. 2023 10h29 HE
|
Dipharma Francis S.r.l
MILAN, Italy, Feb. 10, 2023 (GLOBE NEWSWIRE) -- Dipharma Francis S.r.l. (Dipharma), a global CDMO and leading manufacturer of Active Pharmaceutical Ingredients and advanced Intermediates, announced...
Dipharma receives GMP certification from Brazilian ANVISA
01 déc. 2022 08h46 HE
|
Dipharma Francis S.R.L
MILAN, Italy, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Dipharma Francis S.r.l. (Dipharma), a leading Contract Development and Manufacturing Organization (CDMO) and a global manufacturer of Active...